David Mendelson
Scottsdale, AZNPI 1982631065
Payments from drug & device makers
$823in general payments, 2019–2025
Across 49 payments — averaging $16.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$79
- Pfizer$76
- Johnson & Johnson$74
- Merck$69
- AbbVie$53
- Aidoc Medical Ltd$47
- plus $426 from 15 others
What the payments were for
- Food & beverage$823100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
19
22
25
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 6 | $79 |
| Pfizer | 5 | $76 |
| Johnson & Johnson | 4 | $74 |
| Merck | 5 | $69 |
| AbbVie(2 entities) | 3 | $53 |
| Aidoc Medical Ltd | 1 | $47 |
| E.r. Squibb & Sons, L.L.C. | 4 | $46 |
| Bayer | 3 | $42 |
| Genentech USA, Inc. | 2 | $41 |
| Pharmacyclics LLC, An Abbvie Company | 2 | $39 |
| Puma Biotechnology, Inc. | 2 | $36 |
| Boehringer Ingelheim | 2 | $32 |
| Sanofi | 2 | $28 |
| Kyowa Kirin, Inc. | 1 | $24 |
| Amgen | 1 | $24 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $23 |
| Daiichi Sankyo Inc. | 1 | $20 |
| Ipsen Biopharmaceuticals, Inc | 1 | $18 |
| Stryker | 1 | $18 |
| Astellas Pharma US Inc | 1 | $18 |
| Exelixis Inc. | 1 | $17 |
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.